https://www.fda.gov/safety/medical-product-safety-information/invokana-invokamet-invokamet-xr-canagliflozin-medwatch-safety-alert-boxed-warning-about-risk-leg-and
Based on FDA's review of new data from three clinical trials, the Boxed Warning about amputation risk from the diabetes medicine canagliflozin (Invokana,...
invokamet xrsafety alertboxed warninginvokanacanagliflozin
https://www.pharmaceutical-technology.com/news/newsus-fda-approves-janssens-invokamet-xr-for-type-2-diabetes-treatment-in-adults-5012445/
The US Food and Drug Administration (FDA) has granted approval for Janssen Pharmaceuticals' Invokamet XR to treat type 2 diabetes in adults.
us fdainvokamet xrjanssentype